EGFR and neoplasm: Especially in EGFR‐mutant tumours, RB1 inactivation via complex rearrangements appears to favour SCLC/LUSC transformation under growth inhibitory pressure,125 but this transformation has no significant association with EGFR mutations and is often accompanied by the down‐regulation of EGFR expression.6, 108, 126